التفاصيل البيبلوغرافية
| العنوان: |
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux. |
| المؤلفون: |
Steg, Philippe Gabriel, Jolly, Sanjit S., Mehta, Shamir R., Afzal, Rizwan, Xavier, Dennis, Rupprecht, Hans-Jurgen, López-Sendón, Jose L., Budaj, Andrzej, Diaz, Rafael, Avezum, Álvaro, Widimsky, Petr, Rao, Sunil V., Chrolavicius, Susan, Meeks, Brandi, Joyner, Campbell, Pogue, Janice, Yusuf, Salim |
| المصدر: |
JAMA: Journal of the American Medical Association; 9/22/2010, Vol. 304 Issue 12, p1339-1349, 11p, 1 Diagram, 3 Charts, 3 Graphs |
| مصطلحات موضوعية: |
HEPARIN, CARDIAC patients, CLINICAL drug trials, CORONARY heart disease treatment, DRUG dosage, ANTICOAGULANTS |
| مستخلص: |
The article focuses on a study which compared the safety of two unfractionated heparin regimens during percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation acute coronary syndromes. The study included 2,026 patients undergoing PCI and 3,235 high-risk patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux. Participants were given either low-dose or standard dose unfractionated heparin. Study authors concluded that low-dose unfractionated heparin did not reduce major peri-PCI bleeding and vascular access-site complications. |
| قاعدة البيانات: |
Complementary Index |
